Inventor · disambiguated record
Yuanzan C. Ye
Also filed as: YE YUANZAN · YE YUANZAN C
13 granted patents·155 citations·filing 2001–2012
92Inventor score
Technology areasA61P
Top patents by PatentIndex Score
13 records- 0195US7763609B2Heterocyclic aspartyl protease inhibitorsSCHERING CORP·Filed 2007·Granted Jul 27, 2010·38 cites·12 claims
- 0290US6458812B1Muscarinic antagonistsSCHERING CORP·Filed 2001·Granted Oct 1, 2002·56 cites·14 claims
- 0388US7700603B2Heterocyclic aspartyl protease inhibitorsSCHERING CORP·Filed 2005·Granted Apr 20, 2010·9 cites·8 claims
- 0486US8829036B2Heterocyclic aspartyl protease inhibitorsZHU ZHAONING·Filed 2012·Granted Sep 9, 2014·7 cites·3 claims
- 0586US7973067B2Heterocyclic aspartyl protease inhibitorsSCHERING CORP·Filed 2008·Granted Jul 5, 2011·6 cites·22 claims
- 0685US8691831B2Heterocyclic aspartyl protease inhibitorsZHU ZHAONING·Filed 2012·Granted Apr 8, 2014·7 cites·18 claims
- 0785US8691833B2Heterocyclic aspartyl protease inhibitorsZHU ZHAONING·Filed 2012·Granted Apr 8, 2014·7 cites·9 claims
- 0884US7592348B2Heterocyclic aspartyl protease inhibitorsSCHERING CORP·Filed 2004·Granted Sep 22, 2009·16 cites·41 claims
- 0980US7459450B2Neuropeptide receptor modulatorsSCHERING CORP·Filed 2005·Granted Dec 2, 2008·5 cites·29 claims
- 1077US8242112B2Heterocyclic aspartyl protease inhibitorsZHU ZHAONING·Filed 2011·Granted Aug 14, 2012·2 cites·4 claims
- 1174US8178513B2Heterocyclic aspartyl protease inhibitorsZHU ZHAONING·Filed 2009·Granted May 15, 2012·1 cites·13 claims
- 1262US7504391B2Selective D1/D5 receptor antagonists for the treatment of obesity and CNS disordersSCHERING CORP·Filed 2004·Granted Mar 17, 2009·1 cites·26 claims
- 1361US8778980B2Heterocyclic aspartyl protease inhibitorsZHU ZHAONING·Filed 2012·Granted Jul 15, 2014·0 cites·15 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →